Diffusion tensor imaging of the hippocampus predicts the risk of dementia; the RUN DMC study

Cerebral small vessel disease is one of the most important risk factors for dementia, and has been related to hippocampal atrophy, which is among the first observed changes on conventional MRI in patients with dementia. However, these volumetric changes might be preceded by loss of microstructural integrity of the hippocampus for which conventional MRI is not sensitive enough. Therefore, we investigated the relation between the hippocampal diffusion parameters and the risk of incident dementia, using diffusion tensor imaging, independent of hippocampal volume.

[1]  Wiro J. Niessen,et al.  Structural and diffusion MRI measures of the hippocampus and memory performance , 2012, NeuroImage.

[2]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[3]  P. Basser,et al.  Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.

[4]  C. Caltagirone,et al.  Hippocampal mean diffusivity and memory in healthy elderly individuals , 2010, Neurology.

[5]  D. Norris,et al.  Diffusion tensor imaging of the hippocampus and verbal memory performance: The RUN DMC Study , 2012, Human brain mapping.

[6]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[7]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[8]  Sang Won Seo,et al.  Cortical Thinning in Vascular Mild Cognitive Impairment and Vascular Dementia of Subcortical Type , 2010, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[9]  Carlo Caltagirone,et al.  Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients. , 2010, Journal of Alzheimer's disease : JAD.

[10]  J. Powers,et al.  Diagnostic Criteria for the Neuropathologic Assessment of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[11]  P. Scheltens,et al.  Diffusion changes predict cognitive and functional outcome: The LADIS study , 2013, Annals of neurology.

[12]  R. Clark,et al.  The medial temporal lobe. , 2004, Annual review of neuroscience.

[13]  P. Visser,et al.  New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements. , 2012, Journal of Alzheimer's disease : JAD.

[14]  G. C. Román,et al.  Vascular dementia , 1993, Neurology.

[15]  Christine Stadelmann,et al.  Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis , 2010, Brain pathology.

[16]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[17]  H. Benali,et al.  Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. , 2008, Radiology.

[18]  M. Breteler,et al.  Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.

[19]  J M Wardlaw,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[20]  K. Heilman,et al.  Subcortical vascular dementia , 2005, Neurology.

[21]  David G Norris,et al.  White matter integrity and depressive symptoms in cerebral small vessel disease: The RUN DMC study. , 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[22]  Z. Wszolek,et al.  VASCULAR RISK FACTORS AND DEMENTIA: HOW TO MOVE FORWARD? , 2009, Neurology.

[23]  Marcel P. Zwiers,et al.  Patching cardiac and head motion artefacts in diffusion-weighted images , 2010, NeuroImage.

[24]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[25]  D. Louis Collins,et al.  Diffusion Weighted Image Denoising Using Overcomplete Local PCA , 2013, PloS one.

[26]  A. Hofman,et al.  Cerebral white matter lesions and cognitive function: The Rotterdam scan study , 2000, Annals of neurology.

[27]  P. Basser,et al.  Diffusion tensor MR imaging of the human brain. , 1996, Radiology.

[28]  H S Markus,et al.  Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI. , 1999, Stroke.

[29]  A Hofman,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[30]  R. D'Agostino,et al.  Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. , 2006, Archives of neurology.

[31]  R. Donders,et al.  Cognitive decline following stroke: a comprehensive study of cognitive decline following stroke. , 1998, Journal of clinical and experimental neuropsychology.

[32]  J. Bremner,et al.  MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders , 2005, Molecular Psychiatry.

[33]  Matthias J. Müller,et al.  Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus , 2006, Psychiatry Research: Neuroimaging.

[34]  D. Norris,et al.  Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol , 2011, BMC neurology.

[35]  A. Hofman,et al.  Incidence and risk of dementia. The Rotterdam Study. , 1998, American journal of epidemiology.

[36]  J. Claassen,et al.  Vascular Aspects of Cognitive Impairment and Dementia , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  P. Scheltens,et al.  White Matter Lesions Are Associated With Progression of Medial Temporal Lobe Atrophy in Alzheimer Disease , 2006, Stroke.

[38]  P Alvarez,et al.  Damage limited to the hippocampal region produces long-lasting memory impairment in monkeys , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[40]  Frederik Barkhof,et al.  White matter lesions and hippocampal atrophy in Alzheimer’s disease , 2004, Neurology.

[41]  P. Scheltens,et al.  Dementia: Alzheimer pathology and vascular factors: from mutually exclusive to interaction. , 2012, Biochimica et biophysica acta.

[42]  Matthias J. Müller,et al.  Ultrastructural Hippocampal and White Matter Alterations in Mild Cognitive Impairment: A Diffusion Tensor Imaging Study , 2004, Dementia and Geriatric Cognitive Disorders.

[43]  P. Scheltens,et al.  Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[44]  L. Squire,et al.  Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  L. Launer Demonstrating the case that AD is a vascular disease: epidemiologic evidence , 2002, Ageing Research Reviews.

[46]  E. Richard,et al.  Vascular risk factors as treatment target to prevent cognitive decline. , 2012, Journal of Alzheimer's disease : JAD.

[47]  Laura Fratiglioni,et al.  Worldwide Prevalence and Incidence of Dementia , 1999, Drugs & aging.

[48]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.